nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—head and neck cancer	0.85	1	CbGaD
Pseudoephedrine—NFATC1—hair follicle—head and neck cancer	0.00541	0.147	CbGeAlD
Pseudoephedrine—IL2—neck—head and neck cancer	0.00332	0.0899	CbGeAlD
Pseudoephedrine—NFATC1—connective tissue—head and neck cancer	0.0026	0.0705	CbGeAlD
Pseudoephedrine—IL2—connective tissue—head and neck cancer	0.00238	0.0645	CbGeAlD
Pseudoephedrine—IL2—epithelium—head and neck cancer	0.00226	0.0612	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—head and neck cancer	0.0019	0.0515	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—head and neck cancer	0.00174	0.0471	CbGeAlD
Pseudoephedrine—NFATC1—thyroid gland—head and neck cancer	0.00173	0.0468	CbGeAlD
Pseudoephedrine—IL2—thyroid gland—head and neck cancer	0.00158	0.0428	CbGeAlD
Pseudoephedrine—NFATC1—head—head and neck cancer	0.00153	0.0415	CbGeAlD
Pseudoephedrine—IL2—head—head and neck cancer	0.0014	0.038	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—head and neck cancer	0.00107	0.0291	CbGeAlD
Pseudoephedrine—TNF—lymph node—head and neck cancer	0.00102	0.0277	CbGeAlD
Pseudoephedrine—IL2—lymph node—head and neck cancer	0.000982	0.0266	CbGeAlD
Pseudoephedrine—MAOA—neck—head and neck cancer	0.000652	0.0177	CbGeAlD
Pseudoephedrine—ADRB1—connective tissue—head and neck cancer	0.000597	0.0162	CbGeAlD
Pseudoephedrine—MAOA—parotid gland—head and neck cancer	0.000531	0.0144	CbGeAlD
Pseudoephedrine—MAOA—saliva-secreting gland—head and neck cancer	0.000509	0.0138	CbGeAlD
Pseudoephedrine—MAOA—connective tissue—head and neck cancer	0.000468	0.0127	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—head and neck cancer	0.000448	0.0121	CbGeAlD
Pseudoephedrine—MAOA—trachea—head and neck cancer	0.000393	0.0106	CbGeAlD
Pseudoephedrine—SLC6A3—head—head and neck cancer	0.000371	0.01	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—head and neck cancer	0.000359	0.00971	CbGeAlD
Pseudoephedrine—ADRB1—head—head and neck cancer	0.000352	0.00952	CbGeAlD
Pseudoephedrine—ADRA1A—lymphoid tissue—head and neck cancer	0.000345	0.00934	CbGeAlD
Pseudoephedrine—SLC6A4—head—head and neck cancer	0.00034	0.00919	CbGeAlD
Pseudoephedrine—MAOA—thyroid gland—head and neck cancer	0.000311	0.00841	CbGeAlD
Pseudoephedrine—ADRA2A—trachea—head and neck cancer	0.000301	0.00815	CbGeAlD
Pseudoephedrine—SLC6A2—head—head and neck cancer	0.000299	0.00809	CbGeAlD
Pseudoephedrine—ADRA1A—head—head and neck cancer	0.000278	0.00753	CbGeAlD
Pseudoephedrine—MAOA—head—head and neck cancer	0.000275	0.00746	CbGeAlD
Pseudoephedrine—ADRA2A—thyroid gland—head and neck cancer	0.000238	0.00645	CbGeAlD
Pseudoephedrine—ADRA2A—head—head and neck cancer	0.000211	0.00572	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—head and neck cancer	0.000209	0.00567	CbGeAlD
Pseudoephedrine—MAOA—lymph node—head and neck cancer	0.000193	0.00522	CbGeAlD
Pseudoephedrine—CYP2D6—head—head and neck cancer	0.000164	0.00443	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—head and neck cancer	0.000148	0.00401	CbGeAlD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GRP—head and neck cancer	4.65e-05	0.000415	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—BCL2—head and neck cancer	4.6e-05	0.000411	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PTEN—head and neck cancer	4.5e-05	0.000402	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOTCH1—head and neck cancer	4.49e-05	0.000402	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—UROD—head and neck cancer	4.49e-05	0.000401	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—head and neck cancer	4.47e-05	0.000399	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—head and neck cancer	4.45e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—AKT1—head and neck cancer	4.45e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.38e-05	0.000392	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	4.38e-05	0.000391	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GRP—head and neck cancer	4.32e-05	0.000386	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NAT2—head and neck cancer	4.28e-05	0.000383	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NOTCH1—head and neck cancer	4.25e-05	0.00038	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GRP—head and neck cancer	4.22e-05	0.000377	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—AKT1—head and neck cancer	4.18e-05	0.000374	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTEN—head and neck cancer	4.16e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.15e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—MAPK1—head and neck cancer	4.07e-05	0.000364	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—STAT3—head and neck cancer	4.03e-05	0.00036	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.02e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—AKT1—head and neck cancer	4.01e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GRP—head and neck cancer	3.92e-05	0.000351	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MAPK3—head and neck cancer	3.85e-05	0.000344	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PTEN—head and neck cancer	3.81e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOTCH1—head and neck cancer	3.8e-05	0.00034	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—AKT1—head and neck cancer	3.76e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—DPYD—head and neck cancer	3.75e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KISS1—head and neck cancer	3.74e-05	0.000334	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—STAT3—head and neck cancer	3.72e-05	0.000332	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MAPK1—head and neck cancer	3.66e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KISS1—head and neck cancer	3.66e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—head and neck cancer	3.66e-05	0.000327	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—YAP1—head and neck cancer	3.56e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—MAPK3—head and neck cancer	3.56e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MAPK3—head and neck cancer	3.55e-05	0.000318	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	3.53e-05	0.000316	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.52e-05	0.000314	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—STAT3—head and neck cancer	3.4e-05	0.000304	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.39e-05	0.000303	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—MAPK1—head and neck cancer	3.39e-05	0.000303	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—head and neck cancer	3.39e-05	0.000303	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MAPK1—head and neck cancer	3.38e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—head and neck cancer	3.38e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—MAPK1—head and neck cancer	3.36e-05	0.0003	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—head and neck cancer	3.27e-05	0.000292	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MAPK3—head and neck cancer	3.25e-05	0.000291	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—PIK3CA—head and neck cancer	3.24e-05	0.000289	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—PIK3CA—head and neck cancer	3.18e-05	0.000284	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	3.12e-05	0.000279	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—MAPK1—head and neck cancer	3.12e-05	0.000279	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MAPK1—head and neck cancer	3.1e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—head and neck cancer	3.09e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—head and neck cancer	3.09e-05	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GRP—head and neck cancer	3.08e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KISS1—head and neck cancer	3.03e-05	0.000271	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—head and neck cancer	3.02e-05	0.00027	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GRP—head and neck cancer	3.01e-05	0.000269	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	3e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT6—head and neck cancer	2.99e-05	0.000267	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	2.97e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	2.97e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—PIK3CA—head and neck cancer	2.94e-05	0.000263	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—head and neck cancer	2.94e-05	0.000263	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PIK3CA—head and neck cancer	2.93e-05	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT6—head and neck cancer	2.93e-05	0.000262	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PTEN—head and neck cancer	2.91e-05	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—head and neck cancer	2.88e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NAT2—head and neck cancer	2.86e-05	0.000256	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	2.84e-05	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KISS1—head and neck cancer	2.81e-05	0.000251	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—head and neck cancer	2.72e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—head and neck cancer	2.71e-05	0.000243	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	2.7e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—head and neck cancer	2.69e-05	0.000241	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—PIK3CA—head and neck cancer	2.69e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—YAP1—head and neck cancer	2.65e-05	0.000237	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—AKT1—head and neck cancer	2.64e-05	0.000236	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—head and neck cancer	2.63e-05	0.000235	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—STAT3—head and neck cancer	2.6e-05	0.000233	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—AKT1—head and neck cancer	2.59e-05	0.000232	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—YAP1—head and neck cancer	2.59e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	2.58e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—head and neck cancer	2.55e-05	0.000228	CbGpPWpGaD
Pseudoephedrine—Angina pectoris—Vinblastine—head and neck cancer	2.52e-05	0.0348	CcSEcCtD
Pseudoephedrine—ADRA2A—Metabolism—DPYD—head and neck cancer	2.51e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—head and neck cancer	2.5e-05	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GRP—head and neck cancer	2.49e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—head and neck cancer	2.49e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MAPK3—head and neck cancer	2.49e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—head and neck cancer	2.48e-05	0.000222	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—STAT3—head and neck cancer	2.46e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PTEN—head and neck cancer	2.46e-05	0.00022	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT6—head and neck cancer	2.42e-05	0.000216	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—AKT1—head and neck cancer	2.4e-05	0.000215	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—AKT1—head and neck cancer	2.4e-05	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	2.39e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—YAP1—head and neck cancer	2.38e-05	0.000213	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MAPK1—head and neck cancer	2.37e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—head and neck cancer	2.37e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MAPK3—head and neck cancer	2.35e-05	0.00021	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	2.34e-05	0.00021	CbGpPWpGaD
Pseudoephedrine—Euphoric mood—Fluorouracil—head and neck cancer	2.33e-05	0.0321	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—GRP—head and neck cancer	2.32e-05	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT6—head and neck cancer	2.25e-05	0.000201	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MAPK1—head and neck cancer	2.24e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—head and neck cancer	2.24e-05	0.0002	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—head and neck cancer	2.22e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—Dysuria—Hydroxyurea—head and neck cancer	2.21e-05	0.0305	CcSEcCtD
Pseudoephedrine—IL2—Signaling Pathways—STAT3—head and neck cancer	2.2e-05	0.000197	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—AKT1—head and neck cancer	2.19e-05	0.000196	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—YAP1—head and neck cancer	2.14e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TYMS—head and neck cancer	2.14e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTM1—head and neck cancer	2.11e-05	0.000189	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MAPK3—head and neck cancer	2.1e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PIK3CA—head and neck cancer	2.05e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GPX1—head and neck cancer	2.02e-05	0.000181	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP1A1—head and neck cancer	2e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MAPK1—head and neck cancer	2e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—head and neck cancer	2e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—YAP1—head and neck cancer	1.99e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—head and neck cancer	1.99e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—Blood pressure increased—Docetaxel—head and neck cancer	1.96e-05	0.027	CcSEcCtD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.91e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—head and neck cancer	1.9e-05	0.00017	CbGpPWpGaD
Pseudoephedrine—Hallucination—Hydroxyurea—head and neck cancer	1.88e-05	0.0259	CcSEcCtD
Pseudoephedrine—Irritability—Fluorouracil—head and neck cancer	1.88e-05	0.0259	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—NAT2—head and neck cancer	1.86e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—head and neck cancer	1.82e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—head and neck cancer	1.8e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—Lightheadedness—Docetaxel—head and neck cancer	1.75e-05	0.0241	CcSEcCtD
Pseudoephedrine—IL2—Signaling Pathways—PIK3CA—head and neck cancer	1.74e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—head and neck cancer	1.68e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKT1—head and neck cancer	1.68e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—Angina pectoris—Fluorouracil—head and neck cancer	1.66e-05	0.0228	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.63e-05	0.000146	CbGpPWpGaD
Pseudoephedrine—Vertigo—Vinblastine—head and neck cancer	1.62e-05	0.0224	CcSEcCtD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—head and neck cancer	1.61e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—AKT1—head and neck cancer	1.59e-05	0.000142	CbGpPWpGaD
Pseudoephedrine—Hypertension—Vinblastine—head and neck cancer	1.56e-05	0.0215	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.55e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—head and neck cancer	1.55e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—head and neck cancer	1.53e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—head and neck cancer	1.5e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—MAPK3—head and neck cancer	1.46e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TYMS—head and neck cancer	1.43e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—head and neck cancer	1.42e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTM1—head and neck cancer	1.41e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—Anorexia—Vinblastine—head and neck cancer	1.4e-05	0.0194	CcSEcCtD
Pseudoephedrine—ADRA2A—Hemostasis—MAPK1—head and neck cancer	1.39e-05	0.000125	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—head and neck cancer	1.39e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—head and neck cancer	1.36e-05	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GPX1—head and neck cancer	1.35e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP1A1—head and neck cancer	1.34e-05	0.00012	CbGpPWpGaD
Pseudoephedrine—Anorexia—Hydroxyurea—head and neck cancer	1.28e-05	0.0177	CcSEcCtD
Pseudoephedrine—Decreased appetite—Vinblastine—head and neck cancer	1.28e-05	0.0177	CcSEcCtD
Pseudoephedrine—Pain—Vinblastine—head and neck cancer	1.26e-05	0.0174	CcSEcCtD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	1.24e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—Arrhythmia—Fluorouracil—head and neck cancer	1.22e-05	0.0168	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Vinblastine—head and neck cancer	1.21e-05	0.0167	CcSEcCtD
Pseudoephedrine—ADRA2A—Hemostasis—PIK3CA—head and neck cancer	1.21e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—Dyspnoea—Hydroxyurea—head and neck cancer	1.2e-05	0.0165	CcSEcCtD
Pseudoephedrine—Angina pectoris—Docetaxel—head and neck cancer	1.2e-05	0.0165	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH1—head and neck cancer	1.19e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—head and neck cancer	1.19e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—Dyspepsia—Hydroxyurea—head and neck cancer	1.18e-05	0.0163	CcSEcCtD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—head and neck cancer	1.17e-05	0.000105	CbGpPWpGaD
Pseudoephedrine—Decreased appetite—Hydroxyurea—head and neck cancer	1.17e-05	0.0161	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH1—head and neck cancer	1.17e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—head and neck cancer	1.15e-05	0.000103	CbGpPWpGaD
Pseudoephedrine—Pain—Hydroxyurea—head and neck cancer	1.15e-05	0.0158	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	1.12e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—head and neck cancer	1.12e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—MAPK3—head and neck cancer	1.12e-05	9.99e-05	CbGpPWpGaD
Pseudoephedrine—Feeling abnormal—Hydroxyurea—head and neck cancer	1.11e-05	0.0153	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling by GPCR—MAPK3—head and neck cancer	1.09e-05	9.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—MAPK1—head and neck cancer	1.06e-05	9.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—head and neck cancer	1.06e-05	9.5e-05	CbGpPWpGaD
Pseudoephedrine—Body temperature increased—Hydroxyurea—head and neck cancer	1.06e-05	0.0146	CcSEcCtD
Pseudoephedrine—Asthenia—Vinblastine—head and neck cancer	1.06e-05	0.0146	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—head and neck cancer	1.04e-05	9.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—MAPK1—head and neck cancer	1.04e-05	9.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—head and neck cancer	1.04e-05	9.3e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—head and neck cancer	1.04e-05	9.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CA—head and neck cancer	1.02e-05	9.08e-05	CbGpPWpGaD
Pseudoephedrine—Chest pain—Fluorouracil—head and neck cancer	1.01e-05	0.0139	CcSEcCtD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CA—head and neck cancer	9.94e-06	8.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—head and neck cancer	9.87e-06	8.83e-05	CbGpPWpGaD
Pseudoephedrine—Confusional state—Fluorouracil—head and neck cancer	9.75e-06	0.0134	CcSEcCtD
Pseudoephedrine—Dizziness—Vinblastine—head and neck cancer	9.75e-06	0.0134	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	9.65e-06	8.63e-05	CbGpPWpGaD
Pseudoephedrine—Asthenia—Hydroxyurea—head and neck cancer	9.64e-06	0.0133	CcSEcCtD
Pseudoephedrine—Tachycardia—Fluorouracil—head and neck cancer	9.44e-06	0.013	CcSEcCtD
Pseudoephedrine—Vomiting—Vinblastine—head and neck cancer	9.37e-06	0.0129	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—TYMS—head and neck cancer	9.31e-06	8.33e-05	CbGpPWpGaD
Pseudoephedrine—Headache—Vinblastine—head and neck cancer	9.23e-06	0.0127	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CA—head and neck cancer	9.22e-06	8.25e-05	CbGpPWpGaD
Pseudoephedrine—Anorexia—Fluorouracil—head and neck cancer	9.22e-06	0.0127	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—GSTM1—head and neck cancer	9.2e-06	8.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	9.04e-06	8.08e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CA—head and neck cancer	9.02e-06	8.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH1—head and neck cancer	8.97e-06	8.02e-05	CbGpPWpGaD
Pseudoephedrine—Dizziness—Hydroxyurea—head and neck cancer	8.89e-06	0.0123	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—GPX1—head and neck cancer	8.81e-06	7.88e-05	CbGpPWpGaD
Pseudoephedrine—Arrhythmia—Docetaxel—head and neck cancer	8.78e-06	0.0121	CcSEcCtD
Pseudoephedrine—Nausea—Vinblastine—head and neck cancer	8.75e-06	0.0121	CcSEcCtD
Pseudoephedrine—Insomnia—Fluorouracil—head and neck cancer	8.75e-06	0.0121	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	8.72e-06	7.8e-05	CbGpPWpGaD
Pseudoephedrine—Dyspnoea—Fluorouracil—head and neck cancer	8.62e-06	0.0119	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	8.6e-06	7.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	8.6e-06	7.69e-05	CbGpPWpGaD
Pseudoephedrine—Vomiting—Hydroxyurea—head and neck cancer	8.55e-06	0.0118	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—head and neck cancer	8.53e-06	7.63e-05	CbGpPWpGaD
Pseudoephedrine—Dyspepsia—Fluorouracil—head and neck cancer	8.52e-06	0.0117	CcSEcCtD
Pseudoephedrine—Rash—Hydroxyurea—head and neck cancer	8.47e-06	0.0117	CcSEcCtD
Pseudoephedrine—Dermatitis—Hydroxyurea—head and neck cancer	8.47e-06	0.0117	CcSEcCtD
Pseudoephedrine—Headache—Hydroxyurea—head and neck cancer	8.42e-06	0.0116	CcSEcCtD
Pseudoephedrine—Decreased appetite—Fluorouracil—head and neck cancer	8.41e-06	0.0116	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MAPK3—head and neck cancer	8.4e-06	7.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—head and neck cancer	8.35e-06	7.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—head and neck cancer	8.3e-06	7.42e-05	CbGpPWpGaD
Pseudoephedrine—Pain—Fluorouracil—head and neck cancer	8.27e-06	0.0114	CcSEcCtD
Pseudoephedrine—Muscle spasms—Docetaxel—head and neck cancer	8.23e-06	0.0113	CcSEcCtD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	8.22e-06	7.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—head and neck cancer	8.21e-06	7.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—head and neck cancer	8.12e-06	7.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—head and neck cancer	8.03e-06	7.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—head and neck cancer	8e-06	7.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—MAPK1—head and neck cancer	7.99e-06	7.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—head and neck cancer	7.99e-06	7.14e-05	CbGpPWpGaD
Pseudoephedrine—Nausea—Hydroxyurea—head and neck cancer	7.98e-06	0.011	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Fluorouracil—head and neck cancer	7.97e-06	0.011	CcSEcCtD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—head and neck cancer	7.96e-06	7.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—head and neck cancer	7.83e-06	7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—head and neck cancer	7.72e-06	6.91e-05	CbGpPWpGaD
Pseudoephedrine—Body temperature increased—Fluorouracil—head and neck cancer	7.65e-06	0.0105	CcSEcCtD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CA—head and neck cancer	7.64e-06	6.83e-05	CbGpPWpGaD
Pseudoephedrine—Palpitations—Docetaxel—head and neck cancer	7.56e-06	0.0104	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—head and neck cancer	7.56e-06	6.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—head and neck cancer	7.53e-06	6.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	7.46e-06	6.67e-05	CbGpPWpGaD
Pseudoephedrine—Hypertension—Docetaxel—head and neck cancer	7.39e-06	0.0102	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—head and neck cancer	7.37e-06	6.59e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CA—head and neck cancer	7.33e-06	6.56e-05	CbGpPWpGaD
Pseudoephedrine—Chest pain—Docetaxel—head and neck cancer	7.28e-06	0.01	CcSEcCtD
Pseudoephedrine—Confusional state—Docetaxel—head and neck cancer	7.04e-06	0.0097	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—head and neck cancer	6.98e-06	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—head and neck cancer	6.94e-06	6.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CA—head and neck cancer	6.93e-06	6.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—head and neck cancer	6.91e-06	6.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	6.9e-06	6.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—head and neck cancer	6.82e-06	6.1e-05	CbGpPWpGaD
Pseudoephedrine—Tachycardia—Docetaxel—head and neck cancer	6.81e-06	0.00939	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—head and neck cancer	6.76e-06	6.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	6.71e-06	6e-05	CbGpPWpGaD
Pseudoephedrine—Anorexia—Docetaxel—head and neck cancer	6.66e-06	0.00917	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	6.64e-06	5.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK3—head and neck cancer	6.6e-06	5.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	6.47e-06	5.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK3—head and neck cancer	6.46e-06	5.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—head and neck cancer	6.42e-06	5.74e-05	CbGpPWpGaD
Pseudoephedrine—Dizziness—Fluorouracil—head and neck cancer	6.4e-06	0.00882	CcSEcCtD
Pseudoephedrine—Insomnia—Docetaxel—head and neck cancer	6.32e-06	0.0087	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling Pathways—MAPK1—head and neck cancer	6.28e-06	5.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—head and neck cancer	6.28e-06	5.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	6.25e-06	5.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—head and neck cancer	6.24e-06	5.58e-05	CbGpPWpGaD
Pseudoephedrine—Dyspnoea—Docetaxel—head and neck cancer	6.22e-06	0.00858	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—head and neck cancer	6.17e-06	5.52e-05	CbGpPWpGaD
Pseudoephedrine—Vomiting—Fluorouracil—head and neck cancer	6.15e-06	0.00848	CcSEcCtD
Pseudoephedrine—Dyspepsia—Docetaxel—head and neck cancer	6.15e-06	0.00847	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—MAPK1—head and neck cancer	6.14e-06	5.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—head and neck cancer	6.14e-06	5.49e-05	CbGpPWpGaD
Pseudoephedrine—Rash—Fluorouracil—head and neck cancer	6.1e-06	0.00841	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	6.1e-06	5.45e-05	CbGpPWpGaD
Pseudoephedrine—Dermatitis—Fluorouracil—head and neck cancer	6.09e-06	0.0084	CcSEcCtD
Pseudoephedrine—Decreased appetite—Docetaxel—head and neck cancer	6.07e-06	0.00837	CcSEcCtD
Pseudoephedrine—Headache—Fluorouracil—head and neck cancer	6.06e-06	0.00835	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—head and neck cancer	6.02e-06	5.38e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—head and neck cancer	5.99e-06	5.36e-05	CbGpPWpGaD
Pseudoephedrine—Pain—Docetaxel—head and neck cancer	5.97e-06	0.00823	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—head and neck cancer	5.81e-06	5.19e-05	CbGpPWpGaD
Pseudoephedrine—Feeling abnormal—Docetaxel—head and neck cancer	5.75e-06	0.00793	CcSEcCtD
Pseudoephedrine—Nausea—Fluorouracil—head and neck cancer	5.75e-06	0.00792	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—head and neck cancer	5.66e-06	5.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	5.64e-06	5.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	5.59e-06	5e-05	CbGpPWpGaD
Pseudoephedrine—Body temperature increased—Docetaxel—head and neck cancer	5.52e-06	0.00761	CcSEcCtD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CA—head and neck cancer	5.45e-06	4.87e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	5.34e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CA—head and neck cancer	5.33e-06	4.77e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—head and neck cancer	5.27e-06	4.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—head and neck cancer	5.24e-06	4.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—head and neck cancer	5.19e-06	4.64e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—head and neck cancer	5.19e-06	4.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—head and neck cancer	5.16e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	5.08e-06	4.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	5.08e-06	4.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—head and neck cancer	5.04e-06	4.51e-05	CbGpPWpGaD
Pseudoephedrine—Asthenia—Docetaxel—head and neck cancer	5.01e-06	0.00691	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK3—head and neck cancer	4.96e-06	4.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—head and neck cancer	4.93e-06	4.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CA—head and neck cancer	4.9e-06	4.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MAPK1—head and neck cancer	4.72e-06	4.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—head and neck cancer	4.72e-06	4.22e-05	CbGpPWpGaD
Pseudoephedrine—Dizziness—Docetaxel—head and neck cancer	4.62e-06	0.00636	CcSEcCtD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—head and neck cancer	4.52e-06	4.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—head and neck cancer	4.45e-06	3.98e-05	CbGpPWpGaD
Pseudoephedrine—Vomiting—Docetaxel—head and neck cancer	4.44e-06	0.00612	CcSEcCtD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	4.41e-06	3.94e-05	CbGpPWpGaD
Pseudoephedrine—Rash—Docetaxel—head and neck cancer	4.4e-06	0.00607	CcSEcCtD
Pseudoephedrine—Dermatitis—Docetaxel—head and neck cancer	4.4e-06	0.00606	CcSEcCtD
Pseudoephedrine—Headache—Docetaxel—head and neck cancer	4.37e-06	0.00603	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—head and neck cancer	4.35e-06	3.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	4.27e-06	3.81e-05	CbGpPWpGaD
Pseudoephedrine—Nausea—Docetaxel—head and neck cancer	4.15e-06	0.00572	CcSEcCtD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CA—head and neck cancer	4.1e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	4.08e-06	3.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—head and neck cancer	4e-06	3.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—head and neck cancer	3.96e-06	3.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—head and neck cancer	3.79e-06	3.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	3.6e-06	3.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—head and neck cancer	3.35e-06	2.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.19e-06	2.85e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—head and neck cancer	2.61e-06	2.33e-05	CbGpPWpGaD
